Complexo Hospitalario Universitario de Vigo
Centro de atención
Francisco
Marín Ortuño
Publicacións nas que colabora con Francisco Marín Ortuño (49)
2024
-
Elevated Troponins after COVID-19 Hospitalization and Long-Term COVID-19 Symptoms: Incidence, Prognosis, and Clinical Outcomes—Results from a Multi-Center International Prospective Registry (HOPE-2)
Journal of Clinical Medicine, Vol. 13, Núm. 9
-
Therapeutic management of CNIC polypill at discharge from a first acute coronary syndrome in Spain: the PANDORA study
REC: CardioClinics
2023
-
Post-COVID-19 Symptoms and Heart Disease: Incidence, Prognostic Factors, Outcomes and Vaccination: Results from a Multi-Center International Prospective Registry (HOPE 2)
Journal of Clinical Medicine, Vol. 12, Núm. 2
-
Post-COVID-19 syndrome and diabetes mellitus: a propensity-matched analysis of the International HOPE-II COVID-19 Registry
Frontiers in Endocrinology, Vol. 14
2022
-
A Multicenter, Phase 2, Randomized, Placebo-Controlled, Double-Blind, Parallel-Group, Dose-Finding Trial of the Oral Factor XIa Inhibitor Asundexian to Prevent Adverse Cardiovascular Outcomes After Acute Myocardial Infarction
Circulation, Vol. 146, Núm. 16, pp. 1196-1206
-
Aspirin Therapy on Prophylactic Anticoagulation for Patients Hospitalized With COVID-19: A Propensity Score-Matched Cohort Analysis of the HOPE-COVID-19 Registry
Journal of the American Heart Association, Vol. 11, Núm. 13
-
Chronic Oral Anticoagulation Therapy and Prognosis of Patients Admitted to Hospital for COVID-19: Insights from the HOPE COVID-19 Registry
International Journal of Clinical Practice, Vol. 2022
-
Contact pathway in surgical and transcatheter aortic valve replacement
Frontiers in Cardiovascular Medicine, Vol. 9
2021
-
A fond farewell from the editors of Revista Española de Cardiología 2015-2021
Revista Espanola de Cardiologia, Vol. 74, Núm. 5, pp. 451-461
-
Anticoagulation Therapy in Patients With Coronavirus Disease 2019: Results From a Multicenter International Prospective Registry (Health Outcome Predictive Evaluation for Corona Virus Disease 2019 [HOPE-COVID19])
Critical Care Medicine, Vol. 49, Núm. 6, pp. E624-E633
-
Atrial fibrillation in patients with COVID-19. Usefulness of the CHA2DS2-VASc score: an analysis of the international HOPE COVID-19 registry
Revista Espanola de Cardiologia, Vol. 74, Núm. 7, pp. 608-615
-
Baseline CHA2DS2-VASc score and prognosis in octogenarians with non-ST segment elevation acute coronary syndrome
International Journal of Clinical Practice, Vol. 75, Núm. 6
-
Comorbidity burden and revascularization benefit in elderly patients with acute coronary syndrome
Revista Espanola de Cardiologia, Vol. 74, Núm. 9, pp. 765-772
-
Impact of comorbidities in the decision of using invasive management in elderly patients with NSTEACS
REC: Interventional Cardiology, Vol. 3, Núm. 1, pp. 15-20
-
Impact of frailty and atrial fibrillation in elderly patients with acute coronary syndromes
European Journal of Clinical Investigation, Vol. 51, Núm. 5
-
In-hospital outcomes of mechanical complications in acute myocardial infarction: Analysis from a nationwide spanish database
Cardiology Journal, Vol. 28, Núm. 4, pp. 589-597
-
Influencia de las comorbilidades en la decisión del tratamiento invasivo en ancianos con SCASEST
REC: Interventional Cardiology, Vol. 3, Núm. 1, pp. 15-20
-
Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol
Journal of the American College of Cardiology, Vol. 78, Núm. 5, pp. 421-433
-
Mortality risk assessment in Spain and Italy, insights of the HOPE COVID-19 registry
Internal and Emergency Medicine, Vol. 16, Núm. 4, pp. 957-966
-
Prognosis impact of diabetes in elderly women and men with non-st elevation acute coronary syndrome
Journal of Clinical Medicine, Vol. 10, Núm. 19